This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1991 Dec 7;338(8780):1456-7.

doi: 10.1016/0140-6736(91)92755-q.

Meningococcal vaccine trial in Norway

P E Fine

PMID: 1683438
DOI: 10.1016/0140-6736(91)92755-q

Clinical Trial

Meningococcal vaccine trial in Norway

P E Fine. Lancet. 1991.

. 1991 Dec 7;338(8780):1456-7.

doi: 10.1016/0140-6736(91)92755-q.

Author

P E Fine

PMID: 1683438
DOI: 10.1016/0140-6736(91)92755-q

No abstract available

PubMed Disclaimer

Comment on

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.
Bjune G, Høiby EA, Grønnesby JK, Arnesen O, Fredriksen JH, Halstensen A, Holten E, Lindbak AK, Nøkleby H, Rosenqvist E, et al. Bjune G, et al. Lancet. 1991 Nov 2;338(8775):1093-6. doi: 10.1016/0140-6736(91)91961-s. Lancet. 1991. PMID: 1682541 Clinical Trial.

Similar articles

"Herd immunity" and the meningococcal vaccine trial in Norway.
Bjune G. Bjune G. Lancet. 1992 Aug 1;340(8814):315. doi: 10.1016/0140-6736(92)92411-8. Lancet. 1992. PMID: 1353236 No abstract available.
Meningococcal vaccine in sub-Saharan Africa.
Kaninda AV, Varaine F, Henkens M, Paquet C. Kaninda AV, et al. Lancet. 1997 Dec 6;350(9092):1708. doi: 10.1016/s0140-6736(05)64315-2. Lancet. 1997. PMID: 9400541 No abstract available.
Availability of meningococcal vaccine in single-dose vials for travelers and high-risk persons.
Centers for Disease Control (CDC). Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep. 1990 Oct 26;39(42):763. MMWR Morb Mortal Wkly Rep. 1990. PMID: 2120575 No abstract available.
[Meningococcal infection. Immunologic aspects].
Blanco Quirós A, Casado Flores J. Blanco Quirós A, et al. An Esp Pediatr. 1999 Apr;50(4):325-32. An Esp Pediatr. 1999. PMID: 10356822 Review. Spanish. No abstract available.
Preventing meningococcal infection.
[No authors listed] [No authors listed] Drug Ther Bull. 1990 Apr 30;28(9):34-6. Drug Ther Bull. 1990. PMID: 2131249 Review. No abstract available.

See all similar articles

Cited by

Meningococcal vaccines. Current status and future possibilities.
Peltola H. Peltola H. Drugs. 1998 Mar;55(3):347-66. doi: 10.2165/00003495-199855030-00003. Drugs. 1998. PMID: 9530542 Review.
Corresponding type-specificity of vibriocidal and agglutinating activities of Vibrio cholerae antisera: relevance to vaccine immunogenicity.
Preston NW. Preston NW. Epidemiol Infect. 1993 Jun;110(3):489-97. doi: 10.1017/s0950268800050913. Epidemiol Infect. 1993. PMID: 8519314 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information